CSPC PHARMA (01093): CSPC Pharma has submitted its listing application to the Hong Kong Stock Exchange.

CSPC PHARMA (01093) announced that on December 10, 2025, Chiatai Tianqing Pharmaceutical Group Co., Ltd. submitted an application to the Stock Exchange of Hong Kong for listing, proposing to list H shares. After the completion of the proposed listing of H shares, Chiatai Tianqing Pharmaceutical Group Co., Ltd. will still be an indirect subsidiary of the company. The completion of the proposed listing of H shares is subject to approvals from relevant government and regulatory authorities including the China Securities Regulatory Commission, the Stock Exchange of Hong Kong, and others. The company will provide further updates on the progress of the proposed listing of H shares at the appropriate time.